Time, Brain, and History: A Stroke Through the Ages

Presented by

Supreeth Narayana Gowda, MBBS

PGY4 Resident in Neurology

University of Kentucky

And

Genetics and Epilepsy

Presented by

Sergio Jacinto, MD

PGY5 Resident in Child Neurology

University of Kentucky

Tuesday, May 26, 2026

8:00 - 8:50 AM EDT

Zoom only: https://uky.zoom.us/j/81485627103

Upon completion of this activity, participants will be able to:

1. Describe the historical evolution of brain injury and stroke recognition and understanding across major medical eras and cultures.
2. Outline key milestones in acute stroke management, from early supportive care to modern thrombolysis, thrombectomy, and organized stroke systems.
3. Discuss the changing cultural significance of stroke and the progression of management approaches through the centuries.
4. Discuss the growing role of genetics in epilepsy.
5. Describe the role of genetic etiologies in pediatric epilepsy syndromes.
6. Review emerging precision medicine strategies in epilepsy.

Disclosure of Financial Interest Summary

All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.

None of the planners, faculty, and others in control of educational content for this educational activity have a relevant financial relationship(s) to disclose with ineligible companies.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include a discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.